arrow
C

Cristina Smolenschi

gustave roussy
H指数:16
被引数:1,872

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial

伊沃内司单抗联合化疗在晚期或转移性胃癌(GC)或食管胃结合部癌(EGJC)中的应用:UCGI 52 – GRACIE试验

2026-08-300
OAAI
Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study

早期肿瘤学临床试验纳入患者中的急性肾损伤,AKITEP研究的结果

2026-05-260
PRE
Targeting the Liver: Insights from a tertiary center on post-operative hepatic arterial oxaliplatin for Metastatic Colorectal Cancer

靶向肝脏:来自一家三级中心关于转移性结直肠癌术后肝动脉奥沙利铂灌注的见解

2026-03-030
PRE
Lung-only metastatic pancreatic cancer: differences in patients ‘characteristics, molecular profile and survival

肺转移性胰腺癌:患者特征、分子谱和生存差异

2026-01-090
PRE
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patients

肛门鳞状细胞癌的全面分子图谱:1844例患者的组织活检和液体活检分析

2025-11-240
OAAI
Real-World Immunotherapy Outcomes in Unresectable Peritoneal Mesothelioma: A French Experience

不可切除性腹膜间皮瘤的真实世界免疫治疗效果:一项法国经验

2025-10-200
PRE
Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis

结直肠癌腹膜后淋巴结转移的多模式管理:一项单中心回顾性分析

2025-10-140
PRE
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi)

老年患者胆道肿瘤的管理:一项法国多中心回顾性研究(PRONOBIL-ACABi)

2025-10-030
OA
Impact of oncology review meetings on second opinions for patients with gastrointestinal cancer

肿瘤学评审会议对胃肠道癌患者二次诊疗意见的影响

2025-09-200
PRE
ASO Visual Abstract: Multimodal Management of Retroperitoneal Lymph Node Metastases in Colorectal Cancer: A Single-Center Retrospective Analysis

ASO 视觉摘要:结直肠癌腹膜后淋巴结转移的多模式管理:一项单中心回顾性分析

2025-09-050
PRE
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials

年龄不影响抗体药物偶联物的疗效,但与在早期临床试验中入组的癌症患者发生高等级不良事件相关。

2025-05-160
PRE
Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry

T细胞接合剂作为癌症免疫疗法治疗患者的感染并发症:一项来自REISAMIC登记研究的描述性研究

2025-04-010
PRE
Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients

胰腺癌患者FOLFIRINOX化疗毒性的预测因素

2025-02-090
PRE
DETECTION OF CIRCULATING TUMOR DNA (CTDNA) IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH GLIOBLASTOMA TREATED IN PHASE I CLINICAL TRIAL
2024-11-110
PRE
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer

用于晚期胰腺癌功能精准医学的类器官

2024-10-012
OA